Evaluation of effectiveness and safety of pharmacist independent prescribers in care homes: cluster randomised controlled trial.
Holland R, Bond C, Alldred DP, Arthur A, Barton G, Birt L, Blacklock J, Blyth A, Cheilari S, Daffu-O'Reilly A, Dalgarno L, Desborough J, Ford J, Grant K, Harry B, Hill H, Hughes C, Inch J, Maskrey V, Myint P, Norris N, Poland F, Shepstone L, Spargo M, Turner D, Watts L, Zermansky A, Wright D.
Holland R, et al.
BMJ. 2023 Feb 14;380:e071883. doi: 10.1136/bmj-2022-071883.
BMJ. 2023.
PMID: 36787910
Free PMC article.
Clinical Trial.
MAIN OUTCOMES MEASURES: The primary outcome was fall rate/person at six months analysed by intention to treat, adjusted for prognostic variables. Secondary outcomes included quality of life (EQ-5D by proxy), Barthel score, Drug Burden Index, hospital admissions, and mortal …
MAIN OUTCOMES MEASURES: The primary outcome was fall rate/person at six months analysed by intention to treat, adjusted for prognostic varia …